Publications by authors named "Sandy Amorin"

Claim this Profile
O
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study.
Amira Marouf, Anne Segolene Cottereau, Salim Kanoun, Paul Deschamps, Michel Meignan, Sandy Amorin

Haematologica· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.
Rémy Gressin, Nicolas Daguindau, Adrian Tempescul, Anne Moreau, Sylvain Carras, Sandy Amorin

Haematologica· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma.
Lorraine Krebs, Sandy Amorin, Pauline Brice, Sophie Guillerm, Jean Menard

Strahlenther Onkol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma.
Anne-Sophie Michallet, Yann Guillermin, Benedicte Deau, Laure Lebras, Stephanie Harel, Sandy Amorin

Haematologica· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.
Julien Lenglet, Catherine Traullé, Nicolas Mounier, Claire Benet, Nicolas Munoz-Bongrand, Sandy Amorin

Leuk Lymphoma· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis